MICHELLE RAMPERSAD: Open Payments
NPI 1518154236 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,006 in 138 payments from 45 companies in 2025. Trend: 2023 $10,412 · 2024 $3,675 · 2025 $3,006
Food & beverage: $2,826Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $596 |
| AstraZeneca Pharmaceuticals LP | 12 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $234 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| Merck Sharp & Dohme LLC | 5 | $118 |
| SOBI, INC | 4 | $115 |
| Incyte Corporation | 5 | $112 |
| Daiichi Sankyo Inc. | 4 | $106 |
| GENZYME CORPORATION | 4 | $93 |
| Celgene Corporation | 3 | $90 |
Products named: RYBREVANT, Nubeqa, Enhertu, IMFINZI, Vonjo, TECVAYLI, ERLEADA, SARCLISA.
Industry payments across FL — which companies pay providers there.
